Yongin, South Korea

Hyung Jin Jun

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cj Healthcare Corporation. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung Jin Jun. Retrieved from https://idiyas.com/inventor/hyung-jin-jun-uu40itcl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyung Jin Jun: Innovator in Pharmaceutical Chemistry

Introduction

Hyung Jin Jun is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications.

Latest Patents

Hyung Jin Jun holds a patent for "Aminoalkylbenzothiazepine derivatives and uses thereof." This invention relates to a novel aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof. The patent also includes a pharmaceutical composition for preventing or treating constipation, which comprises this compound as an active ingredient. He has 1 patent to his name.

Career Highlights

Hyung Jin Jun is currently employed at CJ Healthcare Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in medicinal chemistry has positioned him as a valuable asset to his team.

Collaborations

He collaborates with talented coworkers, including Won-Hyuk Jung and Seung In Kim, who contribute to the research and development efforts at CJ Healthcare Corporation.

Conclusion

Hyung Jin Jun's work exemplifies the impact of innovative thinking in the pharmaceutical sector. His contributions are paving the way for advancements in treatments for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…